Trial to Evaluate the Immunogenicity of Dose Reduction Strategies of the MVA-BN Monkeypox Vaccine

NCT05512949 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

229

Enrollment

NIH

Sponsor class

Conditions

Monkeypox

Interventions

BIOLOGICAL: JYNNEOS

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)